Clinical trial
Hypofractionated Radiotherapy for Prostate Cancer in 20 Sessions
NCT03851926 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypofractionated Radiotherapy for Prostate Cancer in 20 Sessions
- Lead sponsor
- Consorci Sanitari de Terrassa
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 5, 2016
- Completion date
- October 5, 2021
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer